SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001479290-19-000079
Filing Date
2019-07-17
Accepted
2019-07-17 08:05:07
Documents
3
Period of Report
2019-07-16
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Document Format Files

Seq Description Document Type Size
1 8-K rvnc20198-kjuly17.htm 8-K 40142
2 EXHIBIT 99.1 rvnc20198-kjuly17exhib.htm EX-99.1 16497
3 rvnclogoa02.jpg GRAPHIC 20324
  Complete submission text file 0001479290-19-000079.txt   85881
Mailing Address 7555 GATEWAY BLVD. NEWARK CA 94560
Business Address 7555 GATEWAY BLVD. NEWARK CA 94560 510-742-3400
Revance Therapeutics, Inc. (Filer) CIK: 0001479290 (see all company filings)

IRS No.: 770551645 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36297 | Film No.: 19958234
SIC: 2834 Pharmaceutical Preparations